一图读懂:肿瘤标记物

2014-12-26 佚名 医学美图

本文附件:关于此次会议的ppt

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1904429, encodeId=aaec190442961, content=<a href='/topic/show?id=b8aa619690e' target=_blank style='color:#2F92EE;'>#标记物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61969, encryptionId=b8aa619690e, topicName=标记物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1072181, createdName=wjywjy, createdTime=Sat Aug 29 05:44:00 CST 2015, time=2015-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1931820, encodeId=94151931820a8, content=<a href='/topic/show?id=7b6c829e4b8' target=_blank style='color:#2F92EE;'>#肿瘤标记物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82974, encryptionId=7b6c829e4b8, topicName=肿瘤标记物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e07307, createdName=lingaifan, createdTime=Sat Nov 07 09:44:00 CST 2015, time=2015-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=13506, encodeId=14701350692, content=很有用,赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=114f1608266, createdName=momo622, createdTime=Sat Dec 27 17:21:00 CST 2014, time=2014-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=13505, encodeId=a99413505d2, content=很有用,赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=114f1608266, createdName=momo622, createdTime=Sat Dec 27 17:20:00 CST 2014, time=2014-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=13504, encodeId=c395135046c, content=有用,收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=114.253.244.55, createdTime=Sat Dec 27 14:35:00 CST 2014, time=2014-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=13497, encodeId=9bf61349e1a, content=卵巢癌里面没有he4!, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=42.48.37.7, createdTime=Fri Dec 26 23:43:00 CST 2014, time=2014-12-26, status=1, ipAttribution=)]
    2015-08-29 wjywjy
  2. [GetPortalCommentsPageByObjectIdResponse(id=1904429, encodeId=aaec190442961, content=<a href='/topic/show?id=b8aa619690e' target=_blank style='color:#2F92EE;'>#标记物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61969, encryptionId=b8aa619690e, topicName=标记物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1072181, createdName=wjywjy, createdTime=Sat Aug 29 05:44:00 CST 2015, time=2015-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1931820, encodeId=94151931820a8, content=<a href='/topic/show?id=7b6c829e4b8' target=_blank style='color:#2F92EE;'>#肿瘤标记物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82974, encryptionId=7b6c829e4b8, topicName=肿瘤标记物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e07307, createdName=lingaifan, createdTime=Sat Nov 07 09:44:00 CST 2015, time=2015-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=13506, encodeId=14701350692, content=很有用,赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=114f1608266, createdName=momo622, createdTime=Sat Dec 27 17:21:00 CST 2014, time=2014-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=13505, encodeId=a99413505d2, content=很有用,赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=114f1608266, createdName=momo622, createdTime=Sat Dec 27 17:20:00 CST 2014, time=2014-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=13504, encodeId=c395135046c, content=有用,收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=114.253.244.55, createdTime=Sat Dec 27 14:35:00 CST 2014, time=2014-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=13497, encodeId=9bf61349e1a, content=卵巢癌里面没有he4!, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=42.48.37.7, createdTime=Fri Dec 26 23:43:00 CST 2014, time=2014-12-26, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1904429, encodeId=aaec190442961, content=<a href='/topic/show?id=b8aa619690e' target=_blank style='color:#2F92EE;'>#标记物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61969, encryptionId=b8aa619690e, topicName=标记物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1072181, createdName=wjywjy, createdTime=Sat Aug 29 05:44:00 CST 2015, time=2015-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1931820, encodeId=94151931820a8, content=<a href='/topic/show?id=7b6c829e4b8' target=_blank style='color:#2F92EE;'>#肿瘤标记物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82974, encryptionId=7b6c829e4b8, topicName=肿瘤标记物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e07307, createdName=lingaifan, createdTime=Sat Nov 07 09:44:00 CST 2015, time=2015-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=13506, encodeId=14701350692, content=很有用,赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=114f1608266, createdName=momo622, createdTime=Sat Dec 27 17:21:00 CST 2014, time=2014-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=13505, encodeId=a99413505d2, content=很有用,赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=114f1608266, createdName=momo622, createdTime=Sat Dec 27 17:20:00 CST 2014, time=2014-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=13504, encodeId=c395135046c, content=有用,收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=114.253.244.55, createdTime=Sat Dec 27 14:35:00 CST 2014, time=2014-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=13497, encodeId=9bf61349e1a, content=卵巢癌里面没有he4!, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=42.48.37.7, createdTime=Fri Dec 26 23:43:00 CST 2014, time=2014-12-26, status=1, ipAttribution=)]
    2014-12-27 momo622

    很有用,赞一个

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1904429, encodeId=aaec190442961, content=<a href='/topic/show?id=b8aa619690e' target=_blank style='color:#2F92EE;'>#标记物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61969, encryptionId=b8aa619690e, topicName=标记物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1072181, createdName=wjywjy, createdTime=Sat Aug 29 05:44:00 CST 2015, time=2015-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1931820, encodeId=94151931820a8, content=<a href='/topic/show?id=7b6c829e4b8' target=_blank style='color:#2F92EE;'>#肿瘤标记物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82974, encryptionId=7b6c829e4b8, topicName=肿瘤标记物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e07307, createdName=lingaifan, createdTime=Sat Nov 07 09:44:00 CST 2015, time=2015-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=13506, encodeId=14701350692, content=很有用,赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=114f1608266, createdName=momo622, createdTime=Sat Dec 27 17:21:00 CST 2014, time=2014-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=13505, encodeId=a99413505d2, content=很有用,赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=114f1608266, createdName=momo622, createdTime=Sat Dec 27 17:20:00 CST 2014, time=2014-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=13504, encodeId=c395135046c, content=有用,收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=114.253.244.55, createdTime=Sat Dec 27 14:35:00 CST 2014, time=2014-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=13497, encodeId=9bf61349e1a, content=卵巢癌里面没有he4!, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=42.48.37.7, createdTime=Fri Dec 26 23:43:00 CST 2014, time=2014-12-26, status=1, ipAttribution=)]
    2014-12-27 momo622

    很有用,赞一个

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1904429, encodeId=aaec190442961, content=<a href='/topic/show?id=b8aa619690e' target=_blank style='color:#2F92EE;'>#标记物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61969, encryptionId=b8aa619690e, topicName=标记物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1072181, createdName=wjywjy, createdTime=Sat Aug 29 05:44:00 CST 2015, time=2015-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1931820, encodeId=94151931820a8, content=<a href='/topic/show?id=7b6c829e4b8' target=_blank style='color:#2F92EE;'>#肿瘤标记物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82974, encryptionId=7b6c829e4b8, topicName=肿瘤标记物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e07307, createdName=lingaifan, createdTime=Sat Nov 07 09:44:00 CST 2015, time=2015-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=13506, encodeId=14701350692, content=很有用,赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=114f1608266, createdName=momo622, createdTime=Sat Dec 27 17:21:00 CST 2014, time=2014-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=13505, encodeId=a99413505d2, content=很有用,赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=114f1608266, createdName=momo622, createdTime=Sat Dec 27 17:20:00 CST 2014, time=2014-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=13504, encodeId=c395135046c, content=有用,收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=114.253.244.55, createdTime=Sat Dec 27 14:35:00 CST 2014, time=2014-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=13497, encodeId=9bf61349e1a, content=卵巢癌里面没有he4!, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=42.48.37.7, createdTime=Fri Dec 26 23:43:00 CST 2014, time=2014-12-26, status=1, ipAttribution=)]
    2014-12-27 114.253.244.55

    有用,收藏

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1904429, encodeId=aaec190442961, content=<a href='/topic/show?id=b8aa619690e' target=_blank style='color:#2F92EE;'>#标记物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61969, encryptionId=b8aa619690e, topicName=标记物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1072181, createdName=wjywjy, createdTime=Sat Aug 29 05:44:00 CST 2015, time=2015-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1931820, encodeId=94151931820a8, content=<a href='/topic/show?id=7b6c829e4b8' target=_blank style='color:#2F92EE;'>#肿瘤标记物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82974, encryptionId=7b6c829e4b8, topicName=肿瘤标记物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e07307, createdName=lingaifan, createdTime=Sat Nov 07 09:44:00 CST 2015, time=2015-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=13506, encodeId=14701350692, content=很有用,赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=114f1608266, createdName=momo622, createdTime=Sat Dec 27 17:21:00 CST 2014, time=2014-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=13505, encodeId=a99413505d2, content=很有用,赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=114f1608266, createdName=momo622, createdTime=Sat Dec 27 17:20:00 CST 2014, time=2014-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=13504, encodeId=c395135046c, content=有用,收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=114.253.244.55, createdTime=Sat Dec 27 14:35:00 CST 2014, time=2014-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=13497, encodeId=9bf61349e1a, content=卵巢癌里面没有he4!, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=42.48.37.7, createdTime=Fri Dec 26 23:43:00 CST 2014, time=2014-12-26, status=1, ipAttribution=)]
    2014-12-26 42.48.37.7

    卵巢癌里面没有he4!

    0

相关资讯

化疗药的前世今生

说化疗加速死亡,倒也不算是空穴来风,用“三人成虎”来形容更确切。因为,这种谣言从很早以前就开始了。 化疗药的前世今生 现代化疗药物鼻祖的,是氮芥,它有个俗称叫“芥子气”。熟悉战争的朋友一定会联想起很多骇人听闻的故事吧。 没错,它一开始并没有用作药物,而是一战中的致命化学武器。当时,美国病理学家研究受芥子气毒害的士兵,发现他们的骨髓几乎失去了造血功能。直到1942 年,美国胸科大夫古斯塔夫根据

直肠癌和肛门癌放疗研究进展

美国放射治疗及肿瘤学会(ASTRO)于2014年9月14-16日在SanFrancisco召开。ASTRO年会为放疗学界的三大会议之一,其内容丰富度、参会人数位居各会之首,是放射治疗领域的顶级学术盛会。每年,中国医学科学院肿瘤医院放射治疗科遴选出色的学术论文、派遣优秀的专家、中青年医师团队赴会,展示中国放射治疗研究成果,让世界听到中国放疗医师的声音。本次大会,中国医学科学院肿瘤医院放

WCC 2014 :免疫肿瘤学:癌症转化医学

澳大利亚黑素瘤患者Ryan Tilly强烈呼吁快速将一些新药物纳入报销/补贴药物行列。最近发生在澳大利亚的一个事例,药物pilimumab(商品名为Yervoy)被纳入药物优惠项目(PBS)用了长达16个月的时间。在这期间,患者不得不自己筹集资金,很多患者或因缺乏资金或因他们的治疗人员疏忽而错过了治疗。就在各种利益相关者忙着协商赔偿条款的同时,却约有350例患者不治而亡。 墨尔本大学和

ASH 2014:对比亭扎肝素和华法林治疗急性静脉血栓栓塞肿瘤患者的疗效与安全性

北京协和医院血液科朱铁楠副教授应记着邀请对当地时间12月9日上午公布的一项关注肿瘤患者抗栓治疗的最新揭晓临床研究(LBA-2)给予了解读。 与非肿瘤患者相比,肿瘤静脉血栓栓塞症(VTE)患者其血栓事件的复发率及抗凝治疗相关出血事件的发生率均显著增加。尽管目前国际指南推荐在肿瘤VTE患者采用低分子量肝素的抗凝治疗,但其临床证据有限。作为迄今为止针对肿瘤VTE患者最大规模的随机对照研究,本研究进一步

兰瑞肽新用途挖掘,FDA批准治疗胃肠胰腺神经内分泌肿瘤

近日,FDA批准Ipsen Pharma (易普森制药)的lanreotide(兰瑞肽)用于治疗无法切除或中度分化、局部晚期或转移性的胃肠胰腺神经内分泌肿瘤,以延长患者的无进展生存期。此前,lanreotide(兰瑞肽)主要是用来长期治疗那些不能手术或放疗、或是对其无反应的肢端肥大症患者。 此项授权主要是基于一项多中心、国际合作的随机双盲安慰剂对照试验结果(试验 2- 55-52030-72

杨雷:用PET-CT给正常人筛查肿瘤,有必要吗?

今天去北京人民广播电台做节目,给大家分享了如何从生活、饮食习惯方面多加注意,从而达到预防癌症发生的目的。最后由于时间关系,好多听众提出的关于癌症筛查体检等方面的问题没有来得及回答,所以选择几个典型的问题,从自己理解的角度对问题加以解释,希望对大家有所帮助,不足之处,还请大家批评指正。 用PET-CT给正常人筛查肿瘤有无必要?首先看一下数据,2012年北京市户籍人口癌症发病率为313/10